ATH 25.0% 0.5¢ alterity therapeutics limited

therapy for parkinsons clears hurdle, page-2

  1. 4,522 Posts.
    lightbulb Created with Sketch. 110
    hi Pixie,

    I believe the disruption of metals homeostasis in the brain is the root of these neurodegenerative diseases. So if a drug/treatment is not addressing the metal balances, then it is not dealing with the real culprit.

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $625 125K

Buyers (Bids)

No. Vol. Price($)
63 72318906 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 29668676 22
View Market Depth
Last trade - 10.00am 09/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.